SCHEMBL6693874

SCHEMBL6693874

Fc1cccc(Cl)c1CNc1cc(NCc2c(F)cccc2Cl)cc(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.52
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPK1 P28482 1/20 0.51
MPI P34949 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TLR7 Q9NYK1 1/20 0.49
TRPA1 O75762 2/20 0.46
HTT P42858 3/20 0.46
CYP1A2 P05177 1/20 0.45
P2RX1 P51575 2/20 0.45
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
LCK P06239 4/20 0.43
BTK Q06187 4/20 0.43
MAPK14 Q16539 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6696450 0.84 RXFP1 (0.60) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6701678 0.81 RXFP1 (0.72) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL4356068 0.79 RXFP1 (0.55) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL16679725 0.78 RXFP1 (0.64) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6693381 0.77 P2RX1 (0.55) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL6696124 0.75 RXFP1 (0.57) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL4347945 0.73 RXFP1 (0.59) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL4343726 0.73 RXFP1 (0.59) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6693899 0.73 P2RX1 (0.54) RXFP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6690783 0.71 RXFP1 (0.44) RXFP1ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed
WO-2003076388-A2 BIS-ANILINE DERIVATIVES USEFUL AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2003-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 RXFP1 2157/4885ALDH1A1 458/4885MAPT 3951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.